Transfer of Marketing Authorization for “BAQSIMIⓇ nasal powder 3mg” (emergency hypoglycemia treatment) in Japan
Press Release NOTICE – Sucession of BAQSIMIⓇ Nasal Powder 3mg”in Japan : In April 2023, Eli Lilly and Company (headquartered in Indianapolis USA; hereinafter referred
MARKETING AUTHORIZATION TRANSFER APPROVED FOR BAQSIMI® ON BEHALF OF AMPHASTAR PHARMACEUTICALS, INC. IN MEXICO
Press Release Approval of MAT in Mexico for Baqsimi® : On April 24, 2023, Eli Lilly & Co. (“Lilly”) announced that it has entered into
MARKETING AUTHORIZATION TRANSFER APPROVED FOR REDEVANT ON BEHALF OF KOWA COMPANY, LTD. IN MEXICO
Press Release On August 1, 2024 the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) approved the Marketing Authorization Transfer of REDEVANT® from Eli
GLOBAL REGULATORY PARTNERS MEXICO RECEIVES MARKETING APPROVAL OF JYNNEOS® ( MVA-BN®) , MONKEYPOX VACCINE, ON BEHALF OF BAVARIAN NORDIC IN MEXICO
Press Release On June 17th, 2022, Global Regulatory Partner Inc. through its subsidiary in Mexico submitted to the Comisión Federal para la Protección contra Riesgos
GRP Mexico Receives ISO 9001:2015 Certification
On February 2, 2023, Global Regulatory Partner Mexico (GRP-Mexico) received their ISO 9001:2015 Certification. The ISO Process started almost a year ago and the QA
GRP Japan Introduces its MAH Capabilities to PMDA Regulators
Overview: On January 16, 2023, GRP Japan executives meet with a team of PMDA regulatory to introduce their MAH Capabilities in Japan. GRP-Japan has been